Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Analysts
MarketBeat
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty-one research firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, sixteen
NASDAQ:IONS